These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31312455)

  • 21. Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism.
    Lansley SM; Cheah HM; Varano Della Vergiliana JF; Chakera A; Lee YC
    Am J Respir Cell Mol Biol; 2015 Jul; 53(1):105-12. PubMed ID: 25474480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
    Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
    J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil-mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis.
    Barrett CD; Moore PK; Moore EE; Moore HB; Chandler JG; Siddiqui H; Maginot ER; Sauaia A; Pérez-Calatayud AA; Buesing K; Wang J; Davila-Chapa C; Hershberger D; Douglas I; Pieracci FM; Yaffe MB
    Chest; 2024 May; ():. PubMed ID: 38710463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage.
    Gervais DA; Levis DA; Hahn PF; Uppot RN; Arellano RS; Mueller PR
    Radiology; 2008 Mar; 246(3):956-63. PubMed ID: 18309017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous fracture of indwelling pleural catheter.
    Yagnik L; Shrestha R
    Respirol Case Rep; 2018 Nov; 6(8):e00365. PubMed ID: 30237886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.
    Idell S; Florova G; Shetty S; Tucker T; Idell R; Koenig K; Azghani A; Rahman NM; Komissarov A
    Clin Pulm Med; 2017 Jul; 24(4):163-169. PubMed ID: 29081644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.
    Piccolo F; Popowicz N; Wong D; Lee YC
    J Thorac Dis; 2015 Jun; 7(6):999-1008. PubMed ID: 26150913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-establishing indwelling pleural catheter patency with alteplase after failure of streptokinase.
    Faisal M; Nurhanis S; Nik Abeed NN; Ng BH; Ban AY
    Respirol Case Rep; 2020 Oct; 8(7):e00639. PubMed ID: 32774860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications of indwelling pleural catheter use and their management.
    Lui MM; Thomas R; Lee YC
    BMJ Open Respir Res; 2016; 3(1):e000123. PubMed ID: 26870384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of carefully titrated ultra-low doses of alteplase in infected haemothorax caused by initial alteplase use to drain loculated malignant pleural effusion.
    Oh JS; Yoo C; Wong D
    Respirol Case Rep; 2023 Sep; 11(9):e01202. PubMed ID: 37577412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
    Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
    Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
    James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
    Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease.
    Strange C; Baumann MH; Sahn SA; Idell S
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):508-15. PubMed ID: 7842213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indwelling pleural catheter infection and colonisation: a clinical practice review.
    Sethi DK; Webber MA; Mishra EK
    J Thorac Dis; 2024 Mar; 16(3):2196-2204. PubMed ID: 38617774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapleural hemorrhage after administration of tPA: a case report and review of the literature.
    Goralski JL; Bromberg PA; Haithcock B
    Ther Adv Respir Dis; 2009 Dec; 3(6):295-300. PubMed ID: 19934281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory Iodopovidone Instillation Via Indwelling Pleural Catheters For Malignant Pleural Effusions.
    Matus I; Ho P
    J Bronchology Interv Pulmonol; 2019 Oct; 26(4):290-292. PubMed ID: 31107295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrapleural Fibrinolytic Therapy Improves Results With Talc Slurry Pleurodesis.
    Bellini A; Tarrazzi F; Tami C; Patino SH; Block M
    Cureus; 2020 Aug; 12(8):e10122. PubMed ID: 33005537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.